“…However, in other rodent models mRGCs are reported to be vulnerable to IOP damage to the same extent as conventional RGCs (Drouyer et al, 2008;de Zavalía et al, 2011) and recently, in experimental rat and mouse glaucoma models, a 50% loss of mRGCs was described . Similarly, human functional studies investigating PLR and light-induced nocturnal melatonin suppression in glaucoma patients have reported reduced responses in patients compared to controls suggesting a vulnerability of mRGCs in glaucoma (Gracitelli et al, 2016(Gracitelli et al, , 2015(Gracitelli et al, , 2014Kelbsch et al, 2016;Pérez-Rico et al, 2010;Nissen et al, 2014;Rukmini et al, 2015). However, in a severely affected glaucoma patient Zhou and colleagues showed persistence of the PLR implicating the survival of mRGCs despite the severe optic neuropathy (Zhou et al, 2014).…”